Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent via DeepDyve Unlimited fulltext viewing of this article Organize, annotate and mark up articles Printing and downloading restrictions apply

Start free trial

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: November 07, 2022
Accepted: January 09, 2023
Published online: January 13, 2023

Number of Print Pages: 12
Number of Figures: 4
Number of Tables: 4

ISSN: 0250-8095 (Print)
eISSN: 1421-9670 (Online)

For additional information: https://www.karger.com/AJN

Abstract

Introduction: Like metabolic acidosis, earlier stages of acid (H+) stress, including an ongoing H+ challenge in the form of dietary H+, without or with steady-state H+ accumulation but with normal plasma total CO2 (PTCO2) (the latter state known as eubicarbonatemic acidosis), are associated with augmented progression of chronic kidney disease (CKD), but diagnosis of this covert H+ stress is clinically problematic. Prior published studies to identify clinically practical biomarkers of covert H+ stress did not include assessments of either dietary H+ or H+ retention. Methods: We tested plasma pH (PpH), 8-h urine excretion of citrate (UcitV) or ammonium (UNH4+V) as biomarkers of dietary H+ assessed as potential renal acid load (PRAL), and of steady-state H+ retention by comparing observed to expected PTCO2 increase 2 h after an oral NaHCO3 bolus. We recruited 313 non-diabetic participants with PTCO2 ≥ 22 mM to exclude participants with metabolic acidosis and with eGFR (mean [SD], mL/min/1.73 m2) stages G1 (n = 62, 99.2 [7.3]), G2 (n = 167, 73.8 [6.3]), and G3 (n = 84, 39.9 [6.7]). We performed linear regressions (LR) between H+ retention or PRAL (dependent variables) and PpH, UcitV, or UNH4+V (independent variables) after adjusting for eGFR. Results: Steady-state H+ retention (mean [SD], mmol) increased with stage (G1 = 3.8 [12.5], G2 = 18.2 [12.4], and G3 = 25.6 [9.0]). PpH was not significantly associated with PRAL in any group, and its association with H+ retention was significant only for G3 (p < 0.01). UcitV association with PRAL was significant only for G1 (p < 0.01) but not for G2 (p = 0.65) or G3 (p = 0.11). UcitV association with H+ retention was negative for both G2 (p < 0.01) and G3 (p < 0.01) but was not significant for G1 (p = 0.50). Adding UNH4+V to UcitV as a regressor for H+ retention increased r2 only marginally for G2 (0.61–0.63) and G3 (0.75–0.79). UNH4+V association with PRAL was positive (p < 0.01) for G1 and G2 but was not significant for G3 (p = 0.46). UNH4+V association with H+ retention was significant for both G2 (p < 0.04) and G3 (p < 0.01) but diverged directionally, being positive for G2 but negative for G3. Discussion: Among patients with CKD at risk for covert H+ stress, lower UcitV better identified eubicarbonatemic acidosis than UNH4+V because the UNH4+V versus H+ retention relationship diverged between G2 and G3. Neither test identified eubicarbonatemic acidosis with certainty, indicating need for further work to establish a clinically useful test. On the other hand, UNH4+V had better utility identifying increased dietary H+ assessed as PRAL in G1 and G2.

© 2023 S. Karger AG, Basel

References Wesson DE. The continuum of acid stress. Clin J Am Soc Nephrol. 2021;16(8):1292–9. Banerjee T, Crews DC, Wesson DE, Tilea AM, Saran R, Rios-Burrows N, et al. High dietary acid load predicts ESRD among US adults with CKD. J Am Soc Nephrol. 2015;26(7):1693–700. Banerjee T, Crews DC, Wesson DE, McCulloch CE, Johansen KL, Saydah S, et al. Elevated serum anion gap in adults with moderate chronic kidney disease increases risk for progression to end-stage renal disease. Am J Physiol Renal Physiol. 2019;316(6):F1244–53. Wesson DE, Simoni J, Broglio K, Sheather S. Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone. Am J Physiol Ren Physiol. 2011;300(4):F830–7. Vallet M, Metzger M, Haymann J-P, Flamant M, Gauci C, Thervet E, et al. Urinary ammonia and long-term outcomes in chronic kidney disease. Kidney Int. 2015;88(1):137–45. Goraya N, Simoni J, Sager LN, Pruszynski J, Wesson DE. Acid retention in chronic kidney disease is inversely related to GFR. Am J Physiol Ren Physiol. 2018;314(5):F985–91. Goraya N, Simoni J, Sager LN, Madias NE, Wesson DE. Urine citrate excretion as a marker of acid retention in patients without overt metabolic acidosis. Kidney Int. 2019;95(5):1190–6. Goraya N, Simoni J, Sager LN, Mamun A, Madias NE, Wesson DE. Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease. Am J Physiol Ren Physiol. 2019;317(2):F502–11. Alpern RJ. Trade-offs in the adaptation to acidosis. Kidney Int. 1995;47(4):1205–15. Raphael KL, Zhang Y, Ying J, Greene T. Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease. Nephrology. 2014;19(10):648–54. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20(9):2075–84. Goraya N, Simoni J, Jo C-H, Wesson DE. Treatment of metabolic acidosis in individuals with stage 3 CKD with fruits and vegetables or oral NaHCO3 reduces urine angiotensinogen and preserves GFR. Kidney Int. 2014;86(5):1031–8. Di Iorio BR, Bellasi A, Raphael KL, Santoro D, Aucella F, Garofano L, et al. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI study. J Nephrol. 2019;32(6):989–1001. Remer T, Manz F. Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc. 1995;95(7):791–7. Yuan C, Spiegelman D, Rimm EB, Rosner BA, Stampfer MJ, Barnett JB, et al. Validity of a dietary questionnaire assessed by comparison with multiple weighed dietary records or 24-hour recalls. Am J Epidemiol. 2017;185(7):570–84. Wesson DE. Assessing acid retention in humans. Am J Physiology-Renal Physiol. 2011;301(5):F1140–1142. Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int. 2010;78(3):303–9. Goraya N, Simoni J, Jo C, Wesson DE. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int. 2012;81(1):86–93. Breslau NA, Brinkley L, Hill KD, Pak CY. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1988;66(1):140–6. Remer T. Influence of nutrition on acid-base balance-metabolic aspects. Eur J Nutr. 2001;40(5):214–20. Asplin JR. Neglected analytes in the 24-h urine: ammonium and sulfate. Curr Opin Nephrol Hypertens. 2022;31(2):168–74. Nagami GT, Hamm LL. Regulation of acid-base balance in chronic kidney disease. Adv Chronic Kidney Dis. 2017;24(5):274–9. Raphael KL, Carroll DJ, Murray J, Greene T, Beddhu S. Urine ammonium predicts clinical outcomes in hypertensive kidney disease. J Am Soc Nephrol. 2017;28(8):2483–90. Gianella FG, Prado VE, Poindexter JR, Adams-Huet B, Li X, Miller RT, et al. Spot urinary citrate-to-creatinine ratio is a marker for acid-base status in chronic kidney disease. Kidney Int. 2021;99(1):208–17. Kraut JA, Raphael KL. Assessment of acid-base status. Beyond bicarbonate. Clin J Am Soc Nephrol. 2021;16(9):1429–31. . DOI: Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, et al. KDOQI clinical Practice guideline for nutrition in CKD: 2020 Update. Am J Kidney Dis. 2020;76(Suppl 1):S1–107. KDIGO Guidelines, Chapter 3. Management of progression and complications of CKD. Kidney Int 2013; 83 (Suppl 3): 73–90. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–9. Adrogué HJ, Brensilver J, Cohen JJ, Madias NE. Influence of steady-state alterations in acid-base equilibrium on the fate of administered bicarbonate in the dog. J Clin Invest. 1983;71(4):867–83. Raghunand N. Tissue pH measurement by magnetic resonance spectroscopy and imaging. Methods Mol Med. 2006;124:347–64. Regalado M, Yang S, Wesson DE. Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis. 2000;35(4):687–94. Wesson DE. Dietary HCO3 reduces distal tubule acidification by increasing cellular HCO3 secretion. Am J Physiol. 1996;271(1 Pt 2):F132–42. (Renal Fluid and Electrolyte Physiol 40) Cunarro JA, Weiner MW. A comparison of methods for measuring urinary ammonium. Kidney Int. 1974;5(4):303–5. Adrogué HJ, Wesson DE. Acid-base A&W basics in medicine series. 3rd ed. Chicago, Illinois: Independently; 2020. Adrogué HJ, Madias NE. Secondary responses to altered acid-base status: the rules of engagement. J Am Soc Nephrol. 2010;21(6):920–3. Bushinsky DA. Tolerance to sodium in patients with CKD-induced metabolic acidosis: does the accompanying anion matter? Am J Kidney Dis. 2018;73(6):858–65. Article / Publication Details

First-Page Preview

Received: November 07, 2022
Accepted: January 09, 2023
Published online: January 13, 2023

Number of Print Pages: 12
Number of Figures: 4
Number of Tables: 4

ISSN: 0250-8095 (Print)
eISSN: 1421-9670 (Online)

For additional information: https://www.karger.com/AJN